Lloyd Frick

Inhibition of colony-stimulating-factor-1 signaling <i>in vivo</i> with the orally bioavailable cFMS kinase inhibitor GW2580

James G. Conway, Brad McDonald, Janet H. Parham et al. · Proceedings of the National Academy of Sciences · 2005 · 252 citations · Full text

Life Sciences, Pharmacology, Bone Metabolism +14

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

P A Furman, M. Davis, Dennis C. Liotta et al. · Antimicrobial Agents and Chemotherapy · 1992 · 234 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Lamivudine Therapy of WHV-Infected Woodchucks

William S. Mason, John M. Cullen, Gloria Moraleda et al. · Virology · 1998 · 154 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Effects of 3′-azido-3′-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cells

Lloyd Frick, Donald J. Nelson, M H St Clair et al. · Biochemical and Biophysical Research Communications · 1988 · 129 citations

Life Sciences, Biochemistry, Molecular Biology +12

Transition state stabilization by deaminases: Rates of nonenzymatic hydrolysis of adenosine and cytidine

Lloyd Frick, John P. Mac Neela, Richard Wolfenden · Bioorganic Chemistry · 1987 · 90 citations

Life Sciences, Biochemistry, Molecular Biology +14